1
|
De Vincentis F, Manzi I, Di Giorgio V, Mussetto A. Endoscopic full-thickness resection of a residual scar in ascending colon to assess post-EMR complete removal of an Abrikossoff tumor. Dig Liver Dis 2023:S1590-8658(23)00572-8. [PMID: 37121817 DOI: 10.1016/j.dld.2023.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 04/13/2023] [Accepted: 04/14/2023] [Indexed: 05/02/2023]
Affiliation(s)
- F De Vincentis
- Gastroenterology Unit, Azienda Unità Sanitaria Locale della Romagna, Santa Maria delle Croci Hospital, Viale Vincenzo Randi, 5, Ravenna 48121, Italy.
| | - I Manzi
- Gastroenterology Unit, Azienda Unità Sanitaria Locale della Romagna, Santa Maria delle Croci Hospital, Viale Vincenzo Randi, 5, Ravenna 48121, Italy
| | - V Di Giorgio
- Gastroenterology Unit, Azienda Unità Sanitaria Locale della Romagna, Santa Maria delle Croci Hospital, Viale Vincenzo Randi, 5, Ravenna 48121, Italy
| | - A Mussetto
- Gastroenterology Unit, Azienda Unità Sanitaria Locale della Romagna, Santa Maria delle Croci Hospital, Viale Vincenzo Randi, 5, Ravenna 48121, Italy
| |
Collapse
|
2
|
Cennamo V, Landi S, Aragona G, Colecchia A, Conigliaro R, Di Lorenzo D, Di Marco M, Fabbri C, Falcone P, Gaiani F, Manno M, Merighi A, Mussetto A, Peghetti A, Sassateli R, Solfrini V, Zagari RM, Arena R, Bertani H, Binda C, Boarino V, De Padova A, Feletti V, Fuccio L, Iori V, Nervi G, Prati GM, Soriani P, De Palma R. The management of endoscopic retrograde cholangio- pancreatography-related infections risk: results of an italian survey at regional level. Ann Ig 2023; 35:84-91. [PMID: 35442386 DOI: 10.7416/ai.2022.2518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
BACKGROUND AND AIM Among the Endoscopic retrograde cholangiopancreatography (ERCP) adverse events, an increasingly arising problem is the transmission of Multi Drug Resistant (MDR) Bacteria through duodenoscopes. The aim of this survey was to evaluate the current clinical practice of management of ERCP associated infections in Emilia-Romagna, Italy. METHODS An online survey was developed including 12 questions on management of ERCP associated infections risk. The survey was proposed to all 12 endoscopy centers in Emilia Romagna that perform at least > 200 ERCPs per year. RESULTS 11 centers completed the survey (92%). Among all risk factors of ERCP infections, hospitalization in intensive care units, immunosuppressant therapies, and previous MDR infections have achieved a 80 % minimum of concurrence by our respondents. The majority of them did not have a formalized document in their hospital describing categories and risk factors helpful in the detection of patients undergoing ERCP with an high-level infective risk (9/11, 82%). Most centers (8/11, 72%) do not perform screening in patients at risk of ERCP infections. Post procedural monitoring is performed by 6 of 11 centers (55%). CONCLUSION Our survey showed that, at least at regional level, there is a lack of procedures and protocols related to the management of patients at risk of ERCP infections.
Collapse
Affiliation(s)
- V Cennamo
- Gastroenterology and Interventional Endoscopy Unit, Bellaria-Maggiore Hospital, AUSL of Bologna, Italy
| | - S Landi
- Gastroenterology and Interventional Endoscopy Unit, Bellaria-Maggiore Hospital, AUSL of Bologna, Italy
| | - G Aragona
- Department of Internal Medicine, Guglielmo da Saliceto Hospital, Piacenza, Italy
| | - A Colecchia
- Gastroenterology Unit, Department of Medical Specialties, Azienda Ospedaliero-Universitaria and University of Modena and Reggio Emilia, Modena, Italy
| | - R Conigliaro
- Digestive Endoscopy Unit, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, Italy
| | - D Di Lorenzo
- Territorial Assistance Service - Pharmacy and Medical Devices Area, AUSL of Bologna, Italy
| | - M Di Marco
- Gastroenterology and Digestive Endoscopy Unit, Ospedale Infermi Rimini, AUSL della Romagna, Italy
| | - C Fabbri
- Gastroenterology and Digestive Endoscopy Unit, Forlì-Cesena Hospitals, AUSL della Romagna, Italy
| | - P Falcone
- Territorial Assistance Service - Pharmacy and Medical Devices Area, AUSL of Bologna, Italy
| | - F Gaiani
- Gastroenterology and Endoscopy Unit, University Hospital of Parma, Italy
| | - M Manno
- Gastroenterology and Digestive Endoscopy Unit, AUSL Modena, Carpi Hospital and Modena District Network of Gastro-enterology, Italy
| | - A Merighi
- Gastroenterology and Digestive Endoscopy Unit, University Hospital Sant'Anna, Ferrara, Italy
| | - A Mussetto
- Gastroenterology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy
| | - A Peghetti
- Territorial Assistance Service - Pharmacy and Medical Devices Area, AUSL of Bologna, Italy
| | - R Sassateli
- Gastroenterology and Digestive Endoscopy Unit, Azienda USL - IRCCS di Reggio Emilia, Italy
| | - V Solfrini
- Territorial Assistance Service - Pharmacy and Medical Devices Area, AUSL of Bologna, Italy
| | - R M Zagari
- Gastroenterology Unit, Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria and University of Bologna, Italy
| | - R Arena
- Gastroenterology and Digestive Endoscopy Unit, University Hospital Sant'Anna, Ferrara, Italy
| | - H Bertani
- Digestive Endoscopy Unit, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, Italy
| | - C Binda
- Gastroenterology and Digestive Endoscopy Unit, Forlì-Cesena Hospitals, AUSL della Romagna, Italy
| | - V Boarino
- Gastroenterology Unit, Department of Medical Specialties, Azienda Ospedaliero-Universitaria and University of Modena and Reggio Emilia, Modena, Italy
| | - A De Padova
- Gastroenterology and Digestive Endoscopy Unit, Ospedale Infermi Rimini, AUSL della Romagna, Italy
| | - V Feletti
- Gastroenterology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy
| | - L Fuccio
- Gastroenterology Unit, Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria and University of Bologna, Italy
| | - V Iori
- Gastroenterology and Digestive Endoscopy Unit, Azienda USL - IRCCS di Reggio Emilia, Italy
| | - G Nervi
- Gastroenterology and Endoscopy Unit, University Hospital of Parma, Italy
| | - G M Prati
- Department of Internal Medicine, Guglielmo da Saliceto Hospital, Piacenza, Italy
| | - P Soriani
- Gastroenterology and Digestive Endoscopy Unit, AUSL Modena, Carpi Hospital and Modena District Network of Gastro-enterology, Italy
| | - R De Palma
- Hospital Care Service, AUSL Bologna, Italy
| |
Collapse
|
3
|
Baltes P, Dray X, Riccioni M, Pérez-Cuadrado-Robles E, Fedorov E, Wiedbrauck F, Chetcuti Zammit S, Cadoni S, Bruno M, Rondonotti E, Wurm Johansson G, Mussetto A, Beaumont H, Perrod G, McNamara D, Plevris J, Spada C, Pinho R, Rosa B, Hervás N, Carretero C, Tontini G, Keuchel M. CAPSULE ENDOSCOPY IN PATIENTS WITH MECKEL`S DIVERTICULUM- CLINICAL FEATURES AND DIAGNOSTIC FINDINGS – A EUROPEAN MULTICENTRE STUDY. ESGE Days 2022 2022. [DOI: 10.1055/s-0042-1744627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
Affiliation(s)
- P. Baltes
- Agaplesion Bethesda Krankenhaus Bergedorf, Hamburg, Germany
| | - X. Dray
- Hospital Saint Antoine, Sorbonne University, Paris, France
| | - M.E. Riccioni
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | | | - E. Fedorov
- Moscow University Hospital N31, Pirogov Russia National Research Medical University, Moscow, Russian Federation
| | | | | | | | - M. Bruno
- University Hospital City of Science and Health Turin, Turin, Italy
| | | | | | - A. Mussetto
- Santa Maria delle Croci Hospital, Ravenna, Italy
| | - H. Beaumont
- Amsterdam University Medical Center, location VU, Amsterdam, Netherlands
| | - G. Perrod
- Georges Pompidou European Hospital, Paris, France
| | - D. McNamara
- Tallaght University Hospital, Dublin, Ireland
| | - J. Plevris
- The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
| | - C. Spada
- Fondazione Poliambulanza, Brescia, Italy
| | - R. Pinho
- Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal
| | - B. Rosa
- Hospital da Senhora da Oliveira, Guimarães, Portugal
| | - N. Hervás
- Complejo Hospitalario Navarra, Pamplona, Spain
| | | | - G.E. Tontini
- Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M. Keuchel
- Agaplesion Bethesda Krankenhaus Bergedorf, Hamburg, Germany
| |
Collapse
|
5
|
Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 2009; 30:508-15. [PMID: 19519732 DOI: 10.1111/j.1365-2036.2009.04063.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND In short-segment Barrett's oesophagus (SSBO) heartburn may be absent and oesophageal acid exposure time (OAET) assessed with pH-only monitoring may be normal. By detecting reflux episodes independently of their acidity, multichannel intraluminal impedance-pH (MII-pH) monitoring allows a comprehensive characterization of reflux events, either off or on proton pump inhibitor (PPI) therapy. AIM To assess reflux parameters by MII-pH monitoring in newly diagnosed SSBO, at baseline and as modified with PPI therapy. METHODS Short-segment Barrett's oesophagus was defined by oesophageal intestinal metaplasia up to 3 cm in length. 24-h MII-pH monitoring was performed before and during PPI therapy. RESULTS Fifty patients were studied prospectively. Normal OAET was found at baseline in 15 patients (30%), 8 and 2 of whom with a higher than normal number of acid and weakly acidic refluxes, respectively. Overall, abnormal reflux parameters were detected by MII-pH monitoring in 90% of patients. Reflux events were prevalent in the upright period. On PPI therapy, acid refluxes decreased and a correspondent increase in weakly acidic refluxes was observed (median from 48.5 to 9 and from 16 to 57.5, respectively) (P < 0.001). CONCLUSIONS Acid refluxes, mainly in the upright period, characterize SSBO. PPI therapy transforms acid refluxes into weakly acidic refluxes.
Collapse
Affiliation(s)
- M Frazzoni
- Gastroenterologia - Nuovo Ospedale S. Agostino, Modena, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|